We are live on ! Find out more
FCP

Fidelis Capital Partners Portfolio holdings

AUM $1.4B
1-Year Est. Return 31.16%
This Fund
S&P 500
This Quarter Est. Return
+5.76%
1 Year Est. Return
+31.16%
3 Year Est. Return
+98.29%
5 Year Est. Return
10 Year Est. Return
AUM
$840M
AUM Growth
+$137M
Cap. Flow
+$16.6M
Cap. Flow %
1.98%
Top 10 Hldgs %
34.26%
Holding
430
New
52
Increased
220
Reduced
110
Closed
18

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$63M
2
V icon
Visa
V
+$921K
3
LLY icon
Eli Lilly
LLY
+$763K
4
BP icon
BP
BP
+$675K
5
CVS icon
CVS Health
CVS
+$652K

Sector Composition

Rank Sector Weight
1 Technology 22.64%
2 Financials 7.56%
3 Consumer Discretionary 6.51%
4 Healthcare 6.29%
5 Communication Services 5.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HON icon
76
Honeywell
HON
$78B
$2.19M 0.26%
10,540
+503
+5% +$97.6K
ABT icon
77
Abbott
ABT
$187B
$2.18M 0.26%
18,637
+2,254
+14% +$247K
ADBE icon
78
Adobe
ADBE
$105B
$2.18M 0.26%
4,495
-290
-6% -$159K
UNP icon
79
Union Pacific
UNP
$174B
$2.13M 0.25%
8,808
+54
+0.6% +$13.1K
PEP icon
80
PepsiCo
PEP
$190B
$2.06M 0.25%
11,905
+1,675
+16% +$288K
MCD icon
81
McDonald's
MCD
$195B
$2.05M 0.24%
6,869
+48
+0.7% +$13.2K
KLAC icon
82
KLA
KLAC
$259B
$2.04M 0.24%
30,760
+9,800
+47% +$769K
VTEB icon
83
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.3B
$1.96M 0.23%
+39,097
New +$1.98M
XLE icon
84
State Street Energy Select Sector SPDR ETF
XLE
$37.7B
$1.89M 0.23%
42,090
+6
+0% +$268
TMO icon
85
Thermo Fisher Scientific
TMO
$220B
$1.83M 0.22%
3,171
+25
+0.8% +$14.8K
IEMG icon
86
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
$1.78M 0.21%
31,550
+11,927
+61% +$646K
DVY icon
87
iShares Select Dividend ETF
DVY
$23.6B
$1.76M 0.21%
12,963
+325
+3% +$42K
ELV icon
88
Elevance Health
ELV
$85.5B
$1.68M 0.2%
4,051
+499
+14% +$267K
ITOT icon
89
iShares Core S&P Total US Stock Market ETF
ITOT
$97.8B
$1.66M 0.2%
13,161
-5,262
-29% -$637K
EOG icon
90
EOG Resources
EOG
$70.7B
$1.64M 0.2%
13,177
+502
+4% +$63.1K
DHR icon
91
Danaher
DHR
$144B
$1.63M 0.19%
6,369
+317
+5% +$83.9K
AFL icon
92
Aflac
AFL
$62.6B
$1.6M 0.19%
14,265
+777
+6% +$79K
SHY icon
93
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
$1.6M 0.19%
19,397
-40
-0.2% -$3.3K
MCK icon
94
McKesson
MCK
$101B
$1.6M 0.19%
3,179
+1,472
+86% +$820K
WFC icon
95
Wells Fargo
WFC
$264B
$1.58M 0.19%
24,485
+311
+1% +$17.6K
VLO icon
96
Valero Energy
VLO
$85.9B
$1.55M 0.18%
11,675
+536
+5% +$77.8K
FICO icon
97
Fair Isaac
FICO
$22.5B
$1.55M 0.18%
776
+500
+181% +$855K
MU icon
98
Micron Technology
MU
$991B
$1.53M 0.18%
14,536
+340
+2% +$35.6K
VONG icon
99
Vanguard Russell 1000 Growth ETF
VONG
$45B
$1.52M 0.18%
+15,608
New +$1.46M
FAST icon
100
Fastenal
FAST
$59.5B
$1.51M 0.18%
39,826
+1,502
+4% +$50.8K

Similar funds

Fidelis Capital Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Fidelis Capital Partners held 430 positions worth $840M, up 20% from $702M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Fidelis Capital Partners's Q3 2024 filing shows 52 new, 220 increased, 110 reduced and 18 closed positions. Its largest new stake was iShares Russell Top 200 Growth ETF: 20,493 shares worth $4.54M. The largest sale was Broadcom, an estimated $63M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Fidelis Capital Partners's largest Q3 2024 buy was iShares Russell Top 200 Growth ETF: 20,493 shares worth $4.54M.
  • Fidelis Capital Partners added most to Lam Research in Q3 2024, an estimated $10.2M increase.
  • Fidelis Capital Partners's biggest Q3 2024 reduction was Broadcom, cutting an estimated $63M.
  • Fidelis Capital Partners fully exited Valaris in Q3 2024, selling an estimated $637K.
  • Fidelis Capital Partners's ten largest holdings make up 34% of its $840M portfolio in Q3 2024.
  • Fidelis Capital Partners opened 52 new positions and closed 18 in Q3 2024.
  • Fidelis Capital Partners's portfolio value rose 20% quarter-over-quarter to $840M.

Based on Fidelis Capital Partners's 13F filing for Q3 2024, filed 25 Oct 2024.